The Short Version
The central allegation — that an FDA safety committee recommended a 150mg/day maximum for soy protein isolate — is not supported by any FDA document, Federal Register entry, or peer-reviewed source in the evidentiary record. While the FDA did authorize a heart-health label claim tied to 25g/day of soy protein, and two individual FDA scientists raised concerns about isoflavone-related effects, no formal committee ever set a 150mg/day protein limit. The claim conflates milligram-range isoflavone discussions with gram-range protein intake and mischaracterizes individual dissent as an official committee recommendation.